Holimedyk Instytut Zdrowia Psychicznego Sp. J.
- Address
- Ul. Targowa 5, 42-200 Częstochowa, Poland
Holimedyk Instytut Zdrowia Psychicznego - Mental Health Research Institute
Holimedyk Instytut Zdrowia Psychicznego (Mental Health Institute) is a specialized psychiatric research center focused on advancing treatment strategies for mood disorders. The institute conducts innovative clinical trials exploring novel therapeutic approaches and adjunctive treatments to improve outcomes for patients with complex mental health conditions.
- Bipolar affective disorder treatment optimization
- Add-on therapeutic strategies for mood stabilization
- Anti-inflammatory approaches in psychiatric disorders
The center is actively investigating the role of low-dose aspirin as adjunctive therapy in bipolar disorder management, examining how acetylsalicylic acid supplementation may enhance standard treatment protocols. This research reflects a growing interest in the potential anti-inflammatory mechanisms that could benefit patients with bipolar affective disorder, representing an innovative approach to psychiatric care that bridges traditional mood stabilization with emerging biological interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Holimedyk Instytut Zdrowia Psychicznego Sp. J.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Low-Dose Acetylsalicylic Acid as Adjunctive Therapy in Bipolar Affective Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial | Instytut Psychiatrii I Neurologii | Phase II | Recruiting | May 2023 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-05-19 | 2023-05-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.